AVEO Pharmaceuticals, Inc.
ANTI-GDF-15 ANTIBODIES
Last updated:
Abstract:
Monoclonal antibodies that bind and inhibit the activity of human GDF15 are disclosed. The antibodies can be used to treat body weight loss, including cachexia, associated with the over-expression of human GDF15.
Status:
Application
Type:
Utility
Filling date:
19 Mar 2020
Issue date:
8 Apr 2021